Who Owns ADC Therapeutics SA Stock?
NYSE: ADCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 67.56%
- Held by insiders
- 14.42%
- Institutional holders
- 150
- Institutions 67.6%
- Insiders 14.4%
- Public and other 18.0%
Who owns ADC Therapeutics SA stock?
Institutional investors own about 67.6% of ADC Therapeutics SA's shares, spread across 150 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 14.42% of ADCT.
The largest institutional holders are Nantahala Capital Management, LLC (9.65%), Redmile Group, LLC (9.03%) and TCG Crossover Management, LLC (8.92%). Together, the top 10 institutions control 49.9% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their ADCT positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ADCT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Nantahala Capital Management, LLC | 12.33M | 9.65% | +120.2% |
| Redmile Group, LLC | 11.53M | 9.03% | -25.5% |
| TCG Crossover Management, LLC | 11.39M | 8.92% | 0.0% |
| Prosight Management, Lp | 7.82M | 6.13% | -5.7% |
| Blackrock Inc. | 7.02M | 5.50% | +12.3% |
| Point72 Asset Management, L.P. | 3.65M | 2.86% | +7.9% |
| Morgan Stanley | 3.05M | 2.39% | -20.0% |
| Millennium Management Llc | 2.90M | 2.27% | -7.0% |
| Citadel Advisors Llc | 2.05M | 1.61% | +413.7% |
| Goldman Sachs Group Inc | 1.91M | 1.50% | +15.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ADCT
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 2.70M | 2.11% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.15M | 0.90% |
| iShares Trust-iShares Russell 2000 Value ETF | 712.03K | 0.56% |
| iShares Trust-iShares Biotechnology ETF | 706.74K | 0.55% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 523.86K | 0.41% |
| iShares Trust-iShares Micro-Cap ETF | 358.02K | 0.28% |
| VANGUARD WELLINGTON FUND-Vanguard U.S. Momentum Factor ETF | 316.78K | 0.25% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 258.69K | 0.20% |
| iShares Trust-iShares Russell 2000 Growth ETF | 204.48K | 0.16% |
| VANGUARD VARIABLE INSURANCE FUNDS-Small Company Growth Portfolio | 177.08K | 0.14% |
Frequently asked questions
Who is the largest shareholder of ADC Therapeutics SA?
Nantahala Capital Management, LLC is the largest institutional shareholder of ADCT, owning 9.65% of shares outstanding (12.33M shares) as of its latest 13F filing.
What percentage of ADC Therapeutics SA is owned by institutions?
Institutions own about 67.6% of ADCT shares and 78.9% of the public float.
How much of ADC Therapeutics SA do insiders own?
Insiders, such as officers and directors, own about 14.42% of ADCT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.